The root cause: why do so many drugs fail to translate from bench to bedside?
Abstract
1. Despite dazzling advances in genomics, automation, and artificial intelligence, only a minority of drug candidates entering human testing ever reach patients. Phase II—our first real test of eff...
Fields of Study & Subjects
Pharmacovigilance and Adverse Drug Reactions
Pharmaceutical studies and practices
Heart Failure Treatment and Management
Publication details
- Journal / source
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Volume
- 21
- Issue
- 8
- Pages
- 823–826
- Publication date
- 23 April 2026
- Language
- EN